- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07649148
Dietary Tracking in Heart Failure (DOTTIE)
June 15, 2026 updated by: Wilson Tang, The Cleveland Clinic
Dietary Optimization Through Tracking and Integrated Evaluation
Emerging evidence links ultra processed foods (UPFs) to adverse cardiovascular outcomes.
UPFs are often high in sodium, unhealthy fats and added sugars, while being low in essential nutrients and fiber.
UPFs contribute to systemic inflammation, fluid retention, and metabolic dysfunction-key drivers of HF and kidney disease progression.
Traditional dietary counseling often lacks specificity around food processing levels.
Furthermore, the majority of nutrition studies relied on extensive self-reported dietary recall food frequency questionnaires (FFQ) that are subjective, often labor intensive, and difficult to implement practically in the clinical setting.
As such, researchers have developed metabolite scores from blood and urine samples to help quantify UPF consumption, which has the promise to better guide dietary counseling and track process.
Therefore, the aim of this study is to evaluate the feasibility and physiological impact of a structured UPF-reduction dietary intervention in patients with HF, leveraging both digital dietary tools (Cronometer) and biomarker assessments.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jennifer Wilcox
- Phone Number: 216-636-6153
- Email: kirsopj@ccf.org
Study Contact Backup
- Name: Valesha Province, MS
- Phone Number: 216-636-6153
- Email: provinv@ccf.org
Study Locations
-
-
Ohio
-
Cleveland, Ohio, United States, 44195
- Recruiting
- Cleveland Clinic Main Campus
-
Principal Investigator:
- W. H. Wilson Tang, MD
-
Contact:
- Valesha Province, MS
- Phone Number: 216-636-6153
- Email: provinv@ccf.org
-
Contact:
- Jeniffer Wilcox
- Phone Number: 216-636-6153
- Email: kirsopj@ccf.org
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Adults with NYHA Class II-III Heart Failure willing and able to track their diet using a mobile app.
Description
Inclusion Criteria:
- Adults (≥18 years) with NYHA Class II-III HF
- Able to use Cronometer to track dietary intake and able to prepare food at home independently (able to modify dietary intake)
Exclusion Criteria:
- History of heart transplant or LVAD implant
- Unable or unwilling to follow dietary coaching for UPF reduction
- eGFR <30 ml/kg/1.73m2
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Document Ultraprocessed Food (UPF) Consumption in HF
Time Frame: 5 years
|
To improve understanding of UPF consumption (type(s), amount(s), etc.) in patients with heart failure
|
5 years
|
|
Change in ultraprocessed food (UPF) consumption in heart failure patients
Time Frame: 5 Years
|
To investigate the potential for reducing UPF consumption via dietary counseling, Cronometer tracking, and structured patient feedback.
|
5 Years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: W. H. Wilson Tang, MD, The Cleveland Clinic
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
June 1, 2036
Study Completion (Estimated)
June 1, 2040
Study Registration Dates
First Submitted
June 9, 2026
First Submitted That Met QC Criteria
June 11, 2026
First Posted (Actual)
June 16, 2026
Study Record Updates
Last Update Posted (Actual)
June 17, 2026
Last Update Submitted That Met QC Criteria
June 15, 2026
Last Verified
June 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 26-571
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Data will only be shared in aggregate and deidentified.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.